GGrantIndex
← Leaderboards

Flanders Interuniv Inst Biotechnology

Zwijnaarde

Compare ↔
$4,511,486
Total funding
7
Grants

Funding over time

peak $1.2M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,511,486 · 7

By mechanism

R01$4,196,399 · 5
R21$273,479 · 1
F32$41,608 · 1

Investigators at Flanders Interuniv Inst Biotechnology

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Frederic Rousseau$1,016,9341 gr2Joost Schymkowitz$1,016,9341 gr3Renzo Mancuso$532,9961 gr4Colinda Scheele$273,4791 gr

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

1Frederic Rousseau$1,016,9341 gr2Joost Schymkowitz$1,016,9341 gr3Renzo Mancuso$532,9961 gr4Edward M Conway$525,0001 gr5Colinda Scheele$273,4791 gr6Edward Conway$180,8882 gr

Largest grants

The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms$538,380
R01 · FY2024 · AG
The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel FTLD-TDP disease mechanisms$527,612
R01 · FY2025 · AG
Heterotypic amyloid interactions as modulators of selective cellular vulnerability$523,651
R01 · FY2022 · AG
Heterotypic amyloid interactions as modulators of selective cellular vulnerability$521,707
R01 · FY2023 · AG
Heterotypic amyloid interactions as modulators of selective cellular vulnerability$510,259
R01 · FY2024 · AG
Heterotypic amyloid interactions as modulators of selective cellular vulnerability$478,251
R01 · FY2025 · AG
Inter-regulatory function of immune-modulation and angiogenesis in cancer$247,046
R01 · FY2020 · CA
Thrombomodulin Links Coagulation to Inflammation$175,000
R01 · FY2004 · HL
Thrombomodulin Links Coagulation to Inflammation$175,000
R01 · FY2005 · HL
Thrombomodulin Links Coagulation to Inflammation$175,000
R01 · FY2003 · HL
Thrombomodulin Links Coagulation to Inflammation$170,888
R01 · FY2006 · HL
A Universal, M2-protein based influenza A Vaccine$153,605
R01 · FY2007 · AI
Mapping ductal carcinoma in situ in space and time to reveal biomarkers that can predict invasive risk$141,625
R21 · FY2025 · CA
Mapping ductal carcinoma in situ in space and time to reveal biomarkers that can predict invasive risk$131,854
R21 · FY2024 · CA
Blood vessels from adult versus embryonic stem cells$36,108
F32 · FY2003 · HL
Blood vessels from adult versus embryonic stem cells$5,500
F32 · FY2003 · HL